Anonymous ID: 39bef9 March 24, 2019, 9:27 a.m. No.5863755   🗄️.is 🔗kun

>>5863343

>>5862921 (lb)

>daily-raises-psychosis-risk

>>5863168 (lb)

>This study is funded by multiple Pharmaceutical companies and organizations. Plus establishment universities and foundations.

 

Expand Your Thinking

 

You are correct to point out the conflicts of interest inherent in such research and its use as propaganda. As a neurosciencefag, this is a complicated subject with evidence on both sides of the issue. For example, there is actually evidence that suggests that cannabis is used as a mood stabilizer (self medicated) in people diagnosed with bipolar disorder and it’s abrupt discontinuation causing acute manic episodes with psychosis. However, that’s not to say that there is no increased risk of psychotic symptoms associated with cannabis use in vulnerable populations. There are valid justifiable concerns about chronic irresponsible use of cannabis during adolescence, but this is true of all psychoactive drugs including nicotine and psychiatric medications, the latter of which are increasing being used in “supposed” at risk populations for later psychosis. This is very dangerous trend that does NOT receive the same degree of scrutiny as the cannabis issue.

 

Thus, my argument is NOT to simply dismiss what appears on the surface to be ONLY propaganda, but use it to point out the hypocrisy of these institutions in trying to prop up their false dichotomy between “their approved” drugs as “good” and all others as “bad”